9.9 C
New York
Friday, May 10, 2024
HomeMarkets
Markets

Roth Capital Downgrades China Cord Blood To Neutral

By Insider Scoop
0
7
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Related CO
China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal
5 NYSE Healthcare Stocks With The Highest Operating Margin

Roth Capital downgraded China Cord Blood Corp (NYSE: CO) from Buy to Neutral.

The price target for China Cord Blood has been raised from $6.50 to $6.75.

China Cord Blood shares have gained 15.69 percent over the past 52 weeks, while the S&P 500 index has surged 7.21 percent in the same period.

China Cord Blood shares fell 0.16 percent to close at $6.33 yesterday.

Latest Ratings for CO

Date Firm Action From To
Jun 2015 Roth Capital Downgrades Buy Neutral
Mar 2015 Jefferies Maintains Buy
Dec 2012 Aegis Capital Initiates Coverage on Buy

View More Analyst Ratings for CO
View the Latest Analyst Ratings

Posted-In: Roth CapitalDowngrades Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,242FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x